{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:17:17Z","timestamp":1787505437338,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity is a state of excess body fat accumulation, and appears to be closely associated with polycystic ovary syndrome (PCOS). Notably, plausible biological pathways through which obesity can regulate anti-M\u00fcllerian hormone (AMH) production have been proposed, and women with PCOS characteristically have an increased AMH level. Body fat accumulation can be described by body fat percentage (BFP). However, the relationship between BFP and AMH still remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>A total of 87 controls and 156 PCOS patients were divided into lean and overweight\/obese groups, and the PCOS patients were further divided into hyper-AMH and normal-AMH subgroups. Univariate regression was used to assess the unadjusted relationship between AMH and outcome variables, multivariable regression analysis was performed to test whether and how serum AMH levels were associated with BFP after adjusting for other co-variables. Receiver-operating characteristic (ROC) curve analyses were used to test the utility of BFP for the diagnosis of PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      BFP was higher in PCOS patients compared with controls, regardless of obesity. Serum AMH levels were negatively associated with BFP in the PCOS group (r = -0.371;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) but not in the control group (r = -0.095;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.385). Multivariable logistic regression analysis showed that elevated BFP was associated with a high risk of PCOS (odds ratio, 1.290; 95% confidence interval, 1.084\u20131.534,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.004). Furthermore, the combination of BFP and serum AMH into a multivariate model gave an improved area under the curve (AUC) of 88.5%, with a sensitivity of 72.4% and specificity of 87.4%; the positive and negative predictive values were 91.2% and 63.9%, respectively. One limitation of this study is all the conclusion reported was based on small sample size.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Herein, we described the negative correlation between BFP and serum AMH levels for the first time, and the present results highlight the importance of further investigation into the role of BFP, especially in body fat-related AMH change as it relates to the underlying pathogenesis of PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2021.659717","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T02:33:49Z","timestamp":1622774029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum Anti-M\u00fcllerian Hormone Levels Were Negatively Associated With Body Fat Percentage in PCOS Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Er","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic Ovary Syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic Features of the Reproductive Phenotypes of Polycystic Ovary Syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of Obesity on the Risk for Polycystic Ovary Syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","first-page":"1","article-title":"Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation","volume":"894","year":"2000","journal-title":"World Health Organ Tech Rep Ser"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2008.26847","article-title":"Comparisons of Percentage Body Fat, Body Mass Index, Waist Circumference, and Waist-Stature Ratio in Adults","volume":"89","author":"Flegal","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa436","article-title":"Increased Body Mass Index is Associated With A Nondilutional Reduction in Antim\u00fcllerian Hormone","volume":"105","author":"Jaswa","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of Polycystic Ovary Syndrome (PCOS): Revisiting the Threshold Values of Follicle Count on Ultrasound and of the Serum AMH Level for the Definition of Polycystic Ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90783-x","article-title":"Isolation of the Bovine and Human Genes for M\u00fcllerian Inhibiting Substance and Expression of the Human Gene in Animal Cells","volume":"45","author":"Cate","year":"1986","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt062","article-title":"The Physiology and Clinical Utility of anti-Mullerian Hormone in Women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq019","article-title":"Concentrations of AMH and Inhibin-B in Relation to Follicular Diameter in Normal Human Small Antral Follicles","volume":"25","author":"Andersen","year":"2010","journal-title":"Hum Reprod"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian Hormone Serum Concentrations in Normoovulatory and Anovulatory Women of Reproductive Age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian Hormone Levels Reflect Severity of PCOS But are Negatively Influenced by Obesity: Relationship With Increased Luteinizing Hormone Levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det015","article-title":"The Relationship of Serum anti-Mullerian Hormone With Polycystic Ovarian Morphology and Polycystic Ovary Syndrome: A Prospective Cohort Study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum Reprod"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0999","article-title":"Differentiating Between Body Fat and Lean Mass\u2013How Should We Measure Obesity","volume":"4","author":"Szab\u00f3","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B16","volume-title":"The Asia-Pacific Perspective: Redefining Obesity and its Treatment","year":"2000"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.4.7375","article-title":"Pcos\/Troglitazone Study Group. Troglitazone Improves Ovulation and Hirsutism in the Polycystic Ovary Syndrome: A Multicenter, Double Blind, Placebo-Controlled Trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0515","article-title":"Body Mass Index and Ovarian Function are Associated With Endocrine and Metabolic Abnormalities in Women With Hyperandrogenic Syndrome","volume":"158","author":"Cupisti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated Serum Level of Anti-Mullerian Hormone in Patients With Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det072","article-title":"Leptin Suppresses anti-Mullerian Hormone Gene Expression Through the JAK2\/STAT3 Pathway in Luteinized Granulosa Cells of Women Undergoing IVF","volume":"28","author":"Merhi","year":"2013","journal-title":"Hum Reprod"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh485","article-title":"Impact of Overweight and Underweight on Assisted Reproduction Treatment","volume":"19","author":"Fedorcsak","year":"2004","journal-title":"Hum Reprod"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2011.06.010","article-title":"Influence of Female Bodyweight on IVF Outcome: A Longitudinal Multicentre Cohort Study of 487 Infertile Couples","volume":"23","author":"Pinborg","year":"2011","journal-title":"Reprod BioMed Online"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1756-4","article-title":"The Relationship Between anti-M\u00fcllerian Hormone Serum Level and Body Mass Index in a Large Cohort of Infertile Patients","volume":"63","author":"Albu","year":"2019","journal-title":"Endocrine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-015-0540-0","article-title":"Antimullerian Hormone Levels are Inversely Associated With Body Mass Index (BMI) in Women With Polycystic Ovary Syndrome","volume":"32","author":"Kriseman","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz012","article-title":"Associations Between Anti-Mullerian Hormone and Cardiometabolic Health in Reproductive Age Women are Explained by Body Mass Index","volume":"105","author":"Rios","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.09.033","article-title":"Levels of Antim\u00fcllerian Hormone in Serum During the Normal Menstrual Cycle","volume":"105","author":"Lambert-Messerlian","year":"2016","journal-title":"Fertil Steril"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep101","article-title":"The Effect of Weight Loss on anti-M\u00fcllerian Hormone Levels in Overweight and Obese Women With Polycystic Ovary Syndrome and Reproductive Impairment","volume":"24","author":"Thomson","year":"2009","journal-title":"Hum Reprod"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey032","article-title":"Impact of Diet and Bariatric Surgery on anti-M\u00fcllerian Hormone Levels","volume":"33","author":"Nilsson-Condori","year":"2018","journal-title":"Hum Reprod"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201500259","article-title":"Vitamin D in Polycystic Ovary Syndrome: Relationship to Obesity and Insulin Resistance","volume":"60","author":"Joham","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on Women\u2019s Health Aspects of Polycystic Ovary Syndrome (PCOS): The Amsterdam Eshre\/Asrm-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, Obesity and Central Obesity in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.10.015","article-title":"Anti-M\u00fcllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome","volume":"60","author":"Kim","year":"2017","journal-title":"J Adolesc Health"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10055","article-title":"Novel Role for anti-M\u00fcllerian Hormone in the Regulation of GnRH Neuron Excitability and Hormone Secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-018-1756-4","article-title":"Interpretation of Serum Gonadotropin Levels in Hyperprolactinaemia","volume":"107","author":"Abbara","year":"2018","journal-title":"Neuroendocrinology"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.659717\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T02:33:53Z","timestamp":1622774033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.659717\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":34,"alternative-id":["10.3389\/fendo.2021.659717"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.659717","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"article-number":"659717"}}